. 2017 May 23;55(6):1812–1820. doi: 10.1128/JCM.02524-16

TABLE 3.

Mold phase MIC/MEC distribution of 50 E. africanus clinical isolates

Antifungal agent	Test method	No. of isolates with MIC/MEC (mg/liter) of:														GM MIC^a	MIC₅₀/MEC₅₀^a	MIC₉₀/MEC₉₀^a	MIC range^a
Antifungal agent	Test method	≤0.008	0.015	0.03	0.06	0.12	0.25	0.5	1	2	4	8	16	32	≥64	GM MIC^a	MIC₅₀/MEC₅₀^a	MIC₉₀/MEC₉₀^a	MIC range^a
Itraconazole	BMD	35	4	5	2	1	1	2								0.01	0.008	0.06	0.008–0.5
Voriconazole	BMD	37	5	5	3											0.01	0.008	0.03	0.008–0.06
Posaconazole	BMD	32	8	4	4				2							0.01	0.008	0.06	0.008–1
Fluconazole	BMD					34	8	5	1	1		1				0.18	0.12	0.5	0.12–8
Caspofungin	BMD						3		20	23	3	1				1.67	2	2	0.25–8
Micafungin	BMD			1			1		20	11	13	4				1.72	2	4	0.03–8
Anidulafungin	BMD								13	32	5					1.72	2	2	1–4
Flucytosine	BMD														50	208.42	256	256	64–256
Amphotericin B	Etest	24		7	3	6	7	2	1							0.01	0.03	0.25	0.002–1
Itraconazole	Etest	36	1	10	1		1	1								0.01	0.006	0.03	0.002–0.5
Voriconazole	Etest	50														0.001	0.002	0.002	0.002–0.008
Posaconazole	Etest	48	1	1												0.002	0.002	0.004	0.002–0.03

All MICs are in milligrams per milliliter.